文献速递其他结缔组织病

高分辨率CT过渡性变化监测环磷酰胺或霉酚酸酯对系统性硬化相关间质性肺病的影响

Using Transitional Changes on High-Resolution Computed Tomography to Monitor the Impact of Cyclophosphamide or Mycophenolate Mofetil on Systemic Sclerosis-Related Interstitial Lung Disease.
PubMed 文献 · Arthritis Rheumatol · 2019-12-26

结果显示两种治疗均显著促进磨玻璃影和肺纤维化向正常肺模式转变。

要点

  • CYC组和MMF组肺纤维化向正常肺转变的净改善分别为21%和19%。
  • CYC组和MMF组磨玻璃影向正常肺转变的净改善分别为30%和28%。

核心结论

  • 在SSc-ILD免疫抑制治疗中,观察到磨玻璃影和肺纤维化向正常肺模式的显著有利转变。
  • 这些过渡变化有助于深入理解治疗反应的潜在病理生物学。

研究设计与样本

  • 基于Scleroderma Lung Study II,评估基线和治疗2年后容积HRCT扫描中ILD特定模式的定量范围变化。

主要发现

  • CYC组和MMF组全肺平均净改善:肺纤维化向正常肺转变分别为21%和19%。
  • CYC组和MMF组全肺平均净改善:磨玻璃影向正常肺转变分别为30%和28%。
  • CYC组和MMF组全肺平均净改善:肺纤维化向磨玻璃影转变分别为5%和0.5%。
  • 两种治疗从磨玻璃影或肺纤维化向正常肺过渡的总体改善均显著(均P<0.001)。

临床怎么用

  • HRCT上ILD模式间的过渡变化可用于监测SSc-ILD免疫抑制治疗的反应。
  • 磨玻璃影和肺纤维化向正常肺转变的定量分析可为治疗评估提供参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine changes in the extent of specific patterns of interstitial lung disease (ILD) as they transition from one pattern to another in response to immunosuppressive therapy in systemic sclerosis-related ILD (SSc-ILD). METHODS: We evaluated changes in the quantitative extent of specific lung patterns of ILD using volumetric high-resolution computed tomography (HRCT) scans obtained at baseline and after 2 years of therapy in patients treated with either cyclophosphamide (CYC) for 1 year or mycophenolate mofetil (MMF) for 2 years in Scleroderma Lung Study II. ILD patterns included lung fibrosis, ground glass, honeycombing, and normal lung. Net change was calculated as the difference in the probability of change from one ILD pattern to another. Wilcoxon's signed rank test was used to compare the changes. RESULTS: Forty-seven and 50 patients had baseline and follow-up scans in the CYC and MMF groups, respectively. Mean net improvements reflecting favorable changes from one ILD pattern to another in the whole lung in the CYC and MMF groups, respectively, were as follows: from lung fibrosis to a normal lung pattern, 21% and 19%; from a ground-glass pattern to a normal lung pattern, 30% and 28%; and from lung fibrosis to a ground-glass pattern, 5% and 0.5%. The mean overall improvement in transitioning from a ground-glass pattern or lung fibrosis to a normal lung pattern was significant for both treatments (all P < 0.001). CONCLUSION: Significantly favorable transitions from both ground-glass and lung fibrosis ILD patterns to a normal lung pattern were observed in patients undergoing immunosuppressive treatment for SSc-ILD, suggesting the usefulness of examining these transitions for insights into the underlying pathobiology of treatment response.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Kim GHJ, Tashkin DP, Lo P, et al. Using Transitional Changes on High-Resolution Computed Tomography to Monitor the Impact of Cyclophosphamide or Mycophenolate Mofetil on Systemic Sclerosis-Related Interstitial Lung Disease. Arthritis Rheumatol. 2019. PMID: 31430058. doi:10.1002/art.41085

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。